Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $28.77 million. The enterprise value is $37.40 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 95.88 million shares outstanding. The number of shares has increased by 62.19% in one year.
| Current Share Class | 95.88M |
| Shares Outstanding | 95.88M |
| Shares Change (YoY) | +62.19% |
| Shares Change (QoQ) | +28.15% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 4.69% |
| Float | 90.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| Forward PS | 0.70 |
| PB Ratio | 0.26 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.63 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.83 |
Financial Efficiency
Return on equity (ROE) is -138.33% and return on invested capital (ROIC) is -39.24%.
| Return on Equity (ROE) | -138.33% |
| Return on Assets (ROA) | -32.64% |
| Return on Capital (ROIC) | -39.24% |
| Revenue Per Employee | $106,334 |
| Profits Per Employee | -$593,317 |
| Employee Count | 344 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.00 |
Taxes
In the past 12 months, BNGO has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.89% in the last 52 weeks. The beta is 2.37, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 2.37 |
| 52-Week Price Change | -80.89% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 38.55 |
| Average Volume (20 Days) | 3,144,037 |
Short Selling Information
The latest short interest is 7.67 million, so 8.00% of the outstanding shares have been sold short.
| Short Interest | 7.67M |
| Short Previous Month | 6.07M |
| Short % of Shares Out | 8.00% |
| Short % of Float | 8.46% |
| Short Ratio (days to cover) | 4.61 |
Income Statement
In the last 12 months, BNGO had revenue of $36.58 million and -$204.10 million in losses. Loss per share was -$4.18.
| Revenue | 36.58M |
| Gross Profit | 10.60M |
| Operating Income | -104.64M |
| Pretax Income | -204.09M |
| Net Income | -204.10M |
| EBITDA | -91.42M |
| EBIT | -104.64M |
| Loss Per Share | -$4.18 |
Full Income StatementBalance Sheet
The company has $18.94 million in cash and $27.57 million in debt, giving a net cash position of -$8.63 million or -$0.09 per share.
| Cash & Cash Equivalents | 18.94M |
| Total Debt | 27.57M |
| Net Cash | -8.63M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 80.34M |
| Book Value Per Share | 1.14 |
| Working Capital | 23.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$105.18 million and capital expenditures -$923,000, giving a free cash flow of -$106.10 million.
| Operating Cash Flow | -105.18M |
| Capital Expenditures | -923,000 |
| Free Cash Flow | -106.10M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
| Gross Margin | 28.97% |
| Operating Margin | -286.05% |
| Pretax Margin | -557.94% |
| Profit Margin | n/a |
| EBITDA Margin | -249.92% |
| EBIT Margin | -286.05% |
| FCF Margin | -290.07% |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.19% |
| Shareholder Yield | -62.19% |
| Earnings Yield | -709.35% |
| FCF Yield | -368.76% |
Analyst Forecast
The average price target for BNGO is $1.00, which is 233.22% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.00 |
| Price Target Difference | 233.22% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 31.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
BNGO has an Altman Z-Score of -7.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.99 |
| Piotroski F-Score | 3 |